In Brief This Week: Myriad Genetics, Illumina, Quest, and More – 360Dx

NEW YORK Fujifilm Medical Systems said this week that it will integrate Fujifilm Wako Diagnostics into its business, effective Oct. 1. As a result, Fujifilm Wakos portfolio of in vitro diagnostic products will be added to Fujifilm Medicals product offerings. Wako Diagnostics was originally acquired by Fujifilm in 2017 and has been operating as a separate subsidiary.

View original post here:
In Brief This Week: Myriad Genetics, Illumina, Quest, and More - 360Dx

Related Posts